HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 88 filers reported holding HARROW HEALTH INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $289,325 | +31.0% | 20,134 | +73.6% | 0.00% | – |
| Q2 2023 | $220,807 | -69.9% | 11,597 | -66.6% | 0.00% | – |
| Q1 2023 | $734,569 | +387.0% | 34,715 | +239.7% | 0.00% | – |
| Q4 2022 | $150,832 | +1575.9% | 10,219 | +1333.2% | 0.00% | – |
| Q3 2022 | $9,000 | -75.7% | 713 | -85.6% | 0.00% | – |
| Q2 2022 | $37,000 | +8.8% | 4,968 | +0.0% | 0.00% | – |
| Q1 2022 | $34,000 | -12.8% | 4,967 | +11.3% | 0.00% | – |
| Q4 2021 | $39,000 | +457.1% | 4,463 | +466.4% | 0.00% | – |
| Q3 2021 | $7,000 | -76.7% | 788 | -75.2% | 0.00% | – |
| Q2 2021 | $30,000 | -77.6% | 3,178 | -84.0% | 0.00% | – |
| Q1 2021 | $134,000 | +97.1% | 19,811 | +101.6% | 0.00% | – |
| Q4 2020 | $68,000 | +106.1% | 9,828 | +67.9% | 0.00% | – |
| Q3 2020 | $33,000 | -84.1% | 5,852 | -85.3% | 0.00% | – |
| Q2 2020 | $208,000 | +100.0% | 39,912 | +47.0% | 0.00% | – |
| Q1 2020 | $104,000 | +420.0% | 27,152 | +573.1% | 0.00% | – |
| Q1 2019 | $20,000 | – | 4,034 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,140,000 | $29,171,000 | 4.84% |
| Ophir Asset Management Pty Ltd | 1,670,817 | $15,522,000 | 2.73% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 378,389 | $3,515,000 | 1.16% |
| Birchview Capital, LP | 180,000 | $1,672,000 | 1.00% |
| Diametric Capital, LP | 82,443 | $766,000 | 0.55% |
| Precision Wealth Strategies, LLC | 65,530 | $609,000 | 0.52% |
| Uniplan Investment Counsel, Inc. | 507,602 | $4,715,000 | 0.28% |
| BARD ASSOCIATES INC | 86,315 | $802,000 | 0.26% |
| EAM Investors, LLC | 142,272 | $1,322,000 | 0.20% |
| Zebra Capital Management LLC | 15,786 | $147,000 | 0.17% |